Skip to content
Stop using now Drug recall · FDA · Published October 27, 2026

Advagen Pharma Recalls Metoprolol Tartrate Tablets Due to Foreign Material

Advagen Pharma recalls 3,684 bottles of Metoprolol Tartrate 50 mg tablets due to the presence of foreign tablets or capsules. Check your bottle's lot number.

🇺🇸 FDA recall #D-0182-2027DrugAdvagen Pharma ›
✎ GovInfoNow plain-language explainer

Advagen Pharma Limited has recalled one lot of Metoprolol Tartrate Tablets, USP, 50 mg because they may contain foreign tablets or capsules. The affected product was distributed nationwide in the U.S. and is available by prescription only. Consumers should check their medication bottles against the specific lot number identified in the recall. Read more at govinfonow.com/recall/2249315-advagen-pharma-limited-recalls-metoprolol-tartrate-tablets-usp-50-mg.

Source Summary by GovInfoNow · govinfonow.com/recall/2249315-advagen-pharma-limited-recalls-metoprolol-tartrate-tablets-usp-50-mg · Published November 17, 2026 · Updated November 17, 2026 · FDA enforcement record: FDA #D-0182-2027

Cite this page

“Advagen Pharma Recalls Metoprolol Tartrate Tablets Due to Foreign Material.” GovInfoNow, updated November 17, 2026. https://govinfonow.com/recall/2249315-advagen-pharma-limited-recalls-metoprolol-tartrate-tablets-usp-50-mg. Based on FDA recall #D-0182-2027 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0182-2027%22&limit=1).

Advagen Pharma Limited voluntarily recalled Metoprolol Tartrate Tablets, USP, 50 mg due to the presence of foreign tablets or capsules. The Food and Drug Administration announced the Class II recall on Oct. 27, 2026.

How to tell if you have it

  • Brand: Advagen Pharma
  • Product: Metoprolol Tartrate Tablets 50 mg
  • NDC: 72888-210-00
  • Batch#: 2611C065A1
  • Expiry: 05/2028
  • Quantity: 3,684 bottles

The hazard

The recall addresses the presence of foreign tablets or capsules in the Metoprolol Tartrate Tablets. The FDA classified this as a Class II recall.

Context

GovInfoNow's records show other recent recalls of similar products include Teva Recalls Metoclopramide Tablets Due to Foreign Contaminants (2026-09-29) and Novadoz Recalls Atorvastatin 40mg Due to Foreign Tablets (2026-10-21). American Health Packaging also recalled Metoclopramide Tablets due to foreign drug presence on Oct. 6, 2026.

How to tell if you have this one

Look for Metoprolol Tartrate Tablets, USP, 50 mg, Rx Only, distributed by Advagen Pharma Ltd., East Windsor, NJ. The specific recalled item has NDC: 72888-210-00 and Batch#: 2611C065A1 with an expiry date of 05/2028.

  • Brand
    Advagen Pharma
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check Your Medication

    Verify if your bottle matches NDC 72888-210-00 and Batch# 2611C065A1.

  2. Stop Taking the Medication

    Do not consume any tablets from the recalled batch due to the risk of foreign material.

  3. Contact Your Pharmacist or Doctor

    Reach out to your healthcare provider for guidance on replacing the medication and managing your prescription.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “U.S. Nationwide” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA published this recall 15 days after the firm started it.

1. Firm started the recall: Oct 27, 202612. FDA classified it Class II: Nov 10, 202623. Published in FDA’s Enforcement Report: Nov 11, 202634. Added to GovInfoNow: Nov 17, 202642026
  1. Firm started the recall
  2. FDA classified it Class II
  3. Published in FDA’s Enforcement Report
  4. Added to GovInfoNow

Dates from the agency record only; steps without a date are left out.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0182-2027 (October 27, 2026) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0182-2027 to see it in context.
  • Plain-language summary written by qwen3.6:35b-a3b on November 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA